MedDataX Logo

Study Protocol: 10-Year Follow-Up of Patients Screened for Cardiovascular Risk by the "All With Heart" Association - Development of a Morocco-Specific Risk Score

NCT ID: NCT07294937

Last Updated: 2025-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-10-01

Study Completion Date

2026-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cardiovascular diseases (CVDs) are the leading cause of death worldwide, and their prevalence is steadily increasing in Morocco. Between 2010 and 2012, the "All with heart" Association conducted a large-scale cardiovascular screening campaign in the Greater Casablanca region, involving more than 10,000 adults aged over 40 years. This 10-year follow-up study aims to evaluate long-term cardiovascular outcomes and to develop a Morocco-specific cardiovascular risk score. Follow-up data will be collected through phone calls, WhatsApp, or SMS with participants or their families to document cardiovascular deaths, myocardial infarctions, and strokes. Statistical analyses, including survival analysis and multivariate logistic regression, will be used to identify significant risk factors and to construct a predictive risk model tailored to the Moroccan population. The study received a favorable opinion from the Rabat Ethics Committee. Written informed consent will be obtained from all participants or their families prior to data collection. The findings are expected to enhance understanding of cardiovascular risk evolution in Morocco and to provide a validated, population-specific risk score to support prevention and patient management strategies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Diseases (CVD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants screened for cardiovascular risk (TAC cohort)

Participants aged 40 years and older who were screened for cardiovascular risk between 2010 and 2012 by the "All with heart" Association in the Greater Casablanca region. This cohort is being followed 10 years after the initial screening to assess cardiovascular outcomes (death, myocardial infarction, stroke) and to develop a Morocco-specific cardiovascular risk score. No intervention is applied; the study is purely observational.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 40 years or older at the time of the initial screening (2010-2012).
* Individuals who participated in the cardiovascular risk screening campaign conducted by the "All with heart" Association between 2010 and 2012 in the Greater Casablanca region.
* Moroccan nationality.
* Participants or family members who provide written informed consent for participation in the 10-year follow-up study.

Exclusion Criteria

* Individuals who refuse to participate in the follow-up study.
* Participants who have moved and cannot be reached by phone, WhatsApp, or SMS.
* Participants who died from non-cardiovascular causes.
* Non-Moroccan participants.
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

F&C Clinical Trials

UNKNOWN

Sponsor Role collaborator

Moroccan Society of Cardiology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Moroccan Society of Cardiology

Casablanca, , Morocco

Site Status RECRUITING

Cardiology Centre, Mohammed V Military Hospital, Rabat, Morocco

Rabat, , Morocco

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Morocco

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Najat MOUINE, Professor of Cardiology

Role: CONTACT

Phone: +212661202733

Email: [email protected]

Mohamed ALAMI

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mohamed ALAMI, Professor of Cardiology

Role: primary

Najat MOUINE, Professor of Cardiology

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

126/24

Identifier Type: -

Identifier Source: org_study_id